gilteritinib
astellas pharmaceuticals
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'myeloid', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'astellas', 'astellasus']
today at #eha2022, we re sharing data from our phase 3 commodore trial in adult patients with relapsed or refractory (r/r) flt3 mutation-positive acute myeloid leukemia (#aml). learn more about these findings: 
A pharma company dedicated to changing tomorrow by improving the health of people around the world. Tweets for U.S. audience. Guidelines: https://t.co/AJlgiDgp38